News | August 23, 2021
Zydus gets USFDA approval for arthritis drug
Zydus was the first to file an ANDA for Tofacitinib extended-release tablets 22 mg and currently holds 180-day exclusivity on this strength
Zydus was the first to file an ANDA for Tofacitinib extended-release tablets 22 mg and currently holds 180-day exclusivity on this strength
Cosentyx is a proven treatment, supported by long-term five-year sustained efficacy and safety data across several inflammatory conditions and with more than 500,000 patients treated worldwide since launch
Lenalidomide is used to treat cancer and also some anaemia disorders
The group has a total of 320 ANDA approvals
Sputnik V is a two-dose shot and has an efficacy of 91.6% against COVID 19
The aim is to create new genomics solutions that could combat cancer and advance market access
The healthcare vertical is US-focused, has 35-plus clients and 24,000 employees across 34 locations in five countries
Filing for WHO Emergency Use Authorisation this month
India is dependent upon China and other countries for a lot of Key Starting Materials (KSM) for their bulk drug needs.
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
Subscribe To Our Newsletter & Stay Updated
